Table 9.
Characteristics | ACS Culprit Lesion (165 Stents, 2360 Segments) | Nonculprit Lesion (81 Stents, 1299 Segments) | P Value |
---|---|---|---|
VA at BL, mm2 | 19.79±5.76 | 16.09±4.92 | <0.001 |
LA at BL, mm2 | 9.56±2.75 | 8.21±2.29 | <0.001 |
SA at BL, mm2 | 9.56±2.75 | 8.21±2.29 | <0.001 |
PA behind the stent at BL, mm2 | 10.23±3.82 | 7.88±3.39 | <0.001 |
PB behind the stent at BL, % | 50.74±8.72 | 47.63±9.45 | <0.001 |
Minimum ESS at BL, Pa | 1.49±0.89 | 1.73±1.15 | 0.001 |
VA at FU, mm2 | 19.73±5.68 | 16.76±4.69 | <0.001 |
LA at FU, mm2 | 8.29±2.90 | 7.68±2.09 | 0.165 |
SA at FU, mm2 | 9.91±2.89 | 8.28±2.30 | <0.001 |
PA behind the stent at FU, mm2 | 9.82±3.61 | 8.49±3.16 | <0.001 |
PB behind the stent at FU, % | 49.15±8.04 | 49.74±8.78 | <0.001 |
ISH area at FU, mm2 | 1.62±1.85 | 0.59±1.21 | <0.001 |
Delta VA, mm2 | −0.06±2.94 | 0.68±2.28 | <0.001 |
Delta LA, mm2 | −1.27±2.13 | −0.53±1.43 | <0.001 |
Delta SA, mm2 | 0.34±1.49 | 0.07±1.06 | 0.459 |
Delta PA behind the stent, mm2 | −0.40±2.39 | 0.61±2.18 | <0.001 |
Delta PB behind the stent, % | −1.59±7.15 | 2.12±7.93 | <0.001 |
%Delta VA, % | 1.13±17.04 | 5.98±15.14 | <0.001 |
%Delta LA, % | −12.39±20.63 | −4.99±16.04 | <0.001 |
%Delta SA, % | 4.43±15.15 | 1.59±12.63 | 0.427 |
%Delta PA behind the stent, % | 1.68±43.56 | 14.74±36.63 | <0.001 |
%Delta PB behind the stent, % | −1.48±19.97 | 6.59±20.14 | <0.001 |
%ISH area, % | 15.73±16.83 | 6.31±11.51 | <0.001 |
Probability values refer to the univariate analysis and are corrected for the clustering of stents within patients. ACS indicates acute coronary syndrome; BL, baseline; ESS, endothelia shear stress; FU, follow‐up; ISH, in‐stent hyperplasia; LA, lumen area; PA, plaque area; PB, plaque burden; SA, stent area; VA, vessel area.